How new smokeless nicotine products affect teen tobacco use
Project 1
This project tracks how new non-combustible nicotine products like gummies, pouches, and e-cigarettes are being used by U.S. middle and high school students from 2024–2028.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11164648 on NIH RePORTER |
What this research studies
This work adds a tobacco-focused module to the national Monitoring the Future survey of 8th, 10th, and 12th graders to capture use of edible oral nicotine products (gums, lozenges, gummies), pouch products, and e-cigarettes. Researchers will pool several years of survey data (about 221,490 students total) to measure trends in single- and multiple-product use from 2024–2028. The team will examine product features like flavor and nicotine level, reasons teens use products, and links with depressive symptoms and other substance use. They will also compare rural versus urban patterns and combinations of non-combustible and combustible product use.
Who could benefit from this research
Good fit: Ideal participants are U.S. students in 8th, 10th, or 12th grade who complete the Monitoring the Future survey.
Not a fit: Adults, children below 8th grade, and teens who are not enrolled in or sampled by the Monitoring the Future survey are not included and will not directly benefit.
Why it matters
Potential benefit: If successful, the results could help reduce teen nicotine addiction by guiding policies, school prevention programs, and product oversight.
How similar studies have performed: National surveys like Monitoring the Future have successfully tracked youth tobacco trends before, but use of edible oral nicotine products is a newer area with limited prior data.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Leventhal, Adam Matthew — University of Southern California
- Study coordinator: Leventhal, Adam Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.